Welcome to Nephron Research

As the market’s leading independent healthcare equity research provider, we strive to separate market noise from the insights that are essential to the investment process.

Nephron’s primary differentiators lie in our research teams and their approach to equity research. The deep experience and insight of our analysts as well as an intense drive to serve a discerning client base sets us apart. With the sole focus of creating value for clients, Nephron can provide a depth of coverage, breadth of access, and consultative services that traditional models lack.

Delivered via an independent and unbiased subscription-only model, Nephron is directly aligned with our client’s interests and investment processes

Meet The Team

A Better Research Process By Design

At Nephron Research, our experience and connectivity drive deep research products which is supplemented by hyper-relevant corporate access

Process Drives
Insight and
  • 1
    Experience and connectivity drive conversation on emerging themes
  • 2
    Which informs "deep dive" research relevant to investors
  • 3
    And is supplemented with strategic corporate access

Written Research Examples

We tackle the most important debates, react quickly, and provide leading perspective

Managed Care & Facilities

2021 MA Notice Takes a Step Back From a Very Positive Starting Point

Pharma Supply Chain & HCIT

Nephron January Price Auditor: Brand Steady at +4.3%; Generic Deflation Declines to -2.5%


A Closer Look: Cigna/ESI Makes Waves with Ascent Contracting & Econdisc Sourcing GPOs


Events & Corporate Access

Nephron Research Curates Dozens of Events Each Year Designed for Maximum Impact to Client Investment Process

West Coast Innovators Tour

Timely tour of companies that are impacting the healthcare services landscape. Some are large and disruptive like Kaiser, and others are smaller and potentially new to our audience.

Nephron Pharmacy Benefit Mgt Innovation Symposium

Our most heavily attended symposium of the year, the Pharmacy Benefit Management Innovation symposium remains relevant for both biopharma and healthcare services investors.

Legends and Innovators Series with John Gorman

Gorman is THE go-to expert on all things Medicare Advantage. Gorman founded and grew Gorman Health Group into an industry leading consultancy after spending time at CMS (when it was HCFA). Gorman recently left GHG to create Nightingale Partners.

Bespoke Research and Consultative Services

Our independent model and deep healthcare and investment expertise allows us to deliver a full suite of bespoke
and consultative services to investment firms and market participants.

Company Positioning
Proprietary Market Research
Management Education & Feedback
Reporting Best Practices

Of Interest…

Drug Supply Chain & HCIT analyst Eric Percher spends a few minutes examining how Nephron Research estimates for a national opioid settlement have increased over the last 12 months.